NCT01448096
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Chonbuk National University Hospital Jeonju, South Korea
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,652 public trials
850 recruiting studies
Lymphoma trial results
Completed
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01839916
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +134 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University "Mother Theresa" Hospital Center; Oncology Department Tirana, Albania
- CEMIC Saavedra Buenos Aires, Argentina
- Instituto Damic Córdoba, Argentina
- Hospital Privado de Comunidad; Oncology Mar del Plata, Argentina
NCT01055496
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Davis Cancer Pavillion and Shands Medical Plaza Gainesville, Florida, United States
- Shands Cancer Hospital At The University Of Florida Gainesville, Florida, United States
- Shands Hospital at the University of Florida Gainesville, Florida, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Completed
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
NCT02950220
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +46 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT03376958
- Conditions
- Diffuse Large B Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Oncology Department of The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
NCT02809573
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
NCT04028804
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
- Locations
-
- The Hospital for Sick Children Toronto, Ontario, Canada
NCT01722305
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Burkitt Lymphoma, Central Nervous System Lymphoma, +23 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
Completed
Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas
NCT01282424
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
- Locations
-
- St. Jude Medical Center Fullerton, California, United States
- Pacific Shores Medical Group Long Beach, California, United States
- UCLA Los Angeles, California, United States
- Central Coast Medical Oncology Santa Maria, California, United States